Skip to main content

Caliper Announces Plans for 12 Percent Reduction of Workforce and Reorganizes Management Team

NEW YORK, Dec. 5 (GenomeWeb News) - Caliper Technologies announced today that it is again reducing its workforce, with net reductions adding up to 12 percent of its current workforce - a total of 65 people, including seven at the vice president level - as part of its restructuring plan following it acquisition of Zymark in July.

 

Caliper said in a statement it will also make some hires "to accommodate the move of certain functions to the company's Hopkinton headquarters, and to add skill sets which will support the company's strategic direction."

 

The senior management team has been reorganized, with Anne Kopf-Sill, the current vice president microfluidics R&D becoming vice president molecular diagnostics, and Andrew Chow replacing Kopf-Sill, among other announcements.

 

Caliper said that the latest reconfiguration is focusing on rationalizing R&D resources. The company aims to reach cash-flow breakeven by the end of 2005.

 

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.